Atlas Trials

Study Evaluating Vabicaserin in Subjects With Schizophrenia

Clinical trial NCT00563706 · COMPLETED

Trial details

NCT number
NCT00563706
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2007-12-01
Primary completion
2008-06-01
Enrollment
199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.